Differentialindikation bei der behandlung der zwangsstorungen

Translated title of the contribution: Differential indication in the treatment of obsessive-compulsive disorder

A. Kordon*, F. Hohagen

*Corresponding author for this work


Obsessive-compulsive disorder is a frequent psychiatric disease, with neurobiological and psychological factors contributing to its genesis. The drugs of choice in somatic treatment of obsessive-compulsive patients are serotonin reuptake inhibitors, whereas behaviour therapy is the preferred psychotherapeutic approach. A combination of behaviour therapy with serotonin reuptake inhibitors is indicated in case of predominance of obsessions and if depressions are present. Following successful combined treatment, behaviour therapy appears to exert an additional protective effect against relapse.

Translated title of the contributionDifferential indication in the treatment of obsessive-compulsive disorder
Original languageGerman
Issue number7
Pages (from-to)455-457
Number of pages3
Publication statusPublished - 1999

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Differential indication in the treatment of obsessive-compulsive disorder'. Together they form a unique fingerprint.

Cite this